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Abstract 
The coronavirus disease 2019 (COVID-19) pandemic has had a global impact on all 
aspects of healthcare, including surgical procedures.  For urologists, it has affected and will 
continue to influence how we approach the care of patients pre-operatively, intra-
operatively, and post-operatively.  A risk-benefit assessment of each patient undergoing 
surgery should be performed during the COVID-19 pandemic based on the urgency of the 
surgery and the risk of viral illness and transmission. Patients with advanced age and 
comorbidities have a higher incidence of mortality. Routine preoperative testing and 
symptom screening is recommended to identify those with COVID-19. Adequate personal 
protective equipment (PPE) for the surgical team is essential to protect healthcare workers 
and ensure an adequate workforce. For COVID-19 positive or suspected patients, the use 
of N95 respirators is recommended if available. The anesthesia method chosen should 
attempt to minimize aerosolization of the virus.  Negative pressure rooms are strongly 
preferred for intubation/extubation and other aerosolizing procedures for COVID 19 
positive patients or when COVID status is unknown. Although transmission has not yet 
been shown during laparoscopic and robotic procedures, efforts should be made to 
minimize the risk of aerosolization. Ultra low particulate air filters are recommended for 
use during minimally invasive procedures to decrease the risk of viral transmission. 
Thorough cleaning and sterilization should be performed post-operatively with adequate 
time allowed for the operating room air to be cycled after procedures.  COVID-19 patients 
should be separated from non-infected patients at all levels of care including recovery to 
decrease the risk of infection. Future directions will be guided by outcomes and infection 
rates as social distancing guidelines are relaxed and more surgical procedures are 
reintroduced.  Recommendations should be adapted to the local environment and will 
continue to evolve as more data becomes available, the shortage of testing and PPE is 
resolved, and a vaccine and therapeutics for COVID-19 are developed.     
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Introduction 
The first reported cases of coronavirus disease 2019 (COVID-19), which is caused by 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), originated in Wuhan City, 
Hubei Province, China in December 2019.  This respiratory disease spread outside of China, 
leading to outbreaks in Korea, Iran, Italy and eventually the United States and the rest of 
the world.  On March 11, 2020, the World Health Organization (WHO) declared the 
outbreak to be a pandemic. At the time of this writing, there are currently over 1.3 million 
confirmed cases worldwide with total deaths numbering over 74,000.1 This pandemic is 
unlike anything that has been seen in recent history.   
From a urologic surgery perspective, many questions arise regarding the immediate 
and long-term care of our patients.  The goal of this article is to summarize some of the 
current information available on pre-operative, intra-operative, and post-operative care. 
As we gain more knowledge about how the virus behaves, this body of literature will 
inevitably change.  
Preoperative Care 
Infection and Mortality 
The decision to operate has the potential to place the patient, healthcare workers, 
and other hospitalized patients at risk of infection with SARS-CoV-2 and therefore should 
be approached with careful thought and consideration. How long a patient remains 
infectious seems to correlate with the severity of the symptoms experienced.  In a series of 
nine COVID-19 patients in Germany, all with mild symptoms, viral levels were low enough 
for infectious transmission to be effectively minimal by 10 days after symptom onset in all 
patients.2  In another study among 191 hospitalized COVID-19 patients in China, the 
median duration of time of the virus being detectable in amounts to be infectious was 20 
days.3 For patients that did not survive, the virus was detectable at significant levels until 
they succumbed to the disease.  The virus was found up to 37 days after symptom onset in 
the longest case in this patient cohort. In an article published in Nature, the infection rate 
of SARS-CoV-2 was shown to be higher than the seasonal flu based on current estimates.4 
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The question of when to return to work for healthcare professionals who have 
tested positive will impact care. The Centers for Disease Control and Prevention (CDC) 
offers guidelines, which separate decision making into testing-based and non-testing-
based options.5 For the testing-based approach, employees should return to work after 
the fever resolves without the use of medication, respiratory symptoms have improved, 
and two tests for COVID-19 collected ≥24 hours apart have resulted negative.  The non-
testing-based approach involves waiting at least 72 hours after resolution of fever without 
use of medications and with an improvement of respiratory symptoms. In addition, they 
recommend waiting seven days after symptom onset for the non-testing-based approach.  
Lastly, the CDC advises asymptomatic health care professionals with confirmed COVID-19 
cases to wait at least 10 days before returning to work.  
Along with the chance of infection, the risk of death from COVID-19 should be 
weighed when deciding to operate. The worldwide mortality rate at the time of this 
writing is 5.6%.1 However, this is among confirmed cases only and the actual rate is likely 
much lower. In a review of 44,672 COVID-19 patients in China, the overall mortality rate 
was found to be 2.3%.6 In this study, age was significantly associated with increased 
mortality. For instance, mortality increased to 8.8% for patients between the ages of 70-
79. For patients ≥80 years old, the mortality was 14.8%. Medical comorbidities were also
associated with worse clinical outcomes among COVID-19 patients. Cancer as a diagnosis 
increased mortality to 5.6%, diabetes to 7.3%, chronic respiratory issues to 6.3%, 
hypertension to 6%, and cardiovascular disease to 10.5%. Of the over 44,000 patients, 81% 
of cases were mild (defined as presence of fever or cough), 14% were severe (as defined 
by dyspnea or hypoxia requiring supplemental oxygen), and 5% of cases were critical (as 
defined by respiratory failure, shock, or multiorgan failure).  If a patient reached a critical 
state, the fatality rate was 49%.  
Triaging Patients and Pre-operative Evaluation 
To respond to and prepare for the surge of COVID-19 cases during the pandemic, 
hospitals around the world, including urology departments, have canceled elective 
procedures and prioritized only high risk and emergent cases.7 The American College of 
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Surgery offered guidelines on how to prioritize cases by describing the Elective Surgery 
Acuity Scale (ESAS).8  This system divides the procedures into three tiers with the third tier 
being the highest priority cases. They recommend that only cancer and high acuity cases 
be performed. A panel of urologists in Italy gave similar recommendations.9  In addition to 
emergency procedures, they strongly recommended continuing to operate on kidney 
cancer (≥cT2), upper tract urothelial cancer (≥cT1, high grade), muscle invasive bladder 
cancer and refractory carcinoma in situ, prostate cancer (high risk and not a radiation 
candidate), testis cancer, and penile cancer (>T1, grade 3). The panel also recommended 
transurethral resection for bladder tumors >2cm. In a comprehensive review article, 
Puliatti et al offered similar recommendations to prioritize emergency cases and high-risk 
cancer procedures.10  
Selection of cases in a given region will be driven by the total number of cases, the 
projection of number of hospitalized patients during the surge, and the hospital and 
intensive care capacity.  As the number of open hospital beds, ventilators, and personal 
protective equipment (PPE) decreases, postponing all but emergency and urgent surgeries 
becomes life-saving.  Since the start of the pandemic, many have transitioned pre-
operative counseling to telehealth when possible.11  
An important component of the preoperative evaluation for protecting patients 
and healthcare workers is testing for SARS-CoV-2. Most recommendations, such as those 
from the CDC, only recommend testing patients with symptoms.12 However, a significant 
proportion of COVID-19 patients are asymptomatic. A group at the University of Oxford 
reviewed 21 studies on the subject and found that anywhere between 5 to 80% of COVID-
19 positive patients may be asymptomatic depending on the population studied.13 
Knowledge of the patient being positive for the disease is important to know for 
intraoperative care in protecting those in the operating room and for post-operative care 
in isolating the patient from other inpatients. Surgeons should also be aware that testing 
has its limitations.  Yang et al found that nasopharyngeal and oropharyngeal testing has 
only a 60 to 70% sensitivity.14 Serologic testing has higher sensitivity at 80 to 100% for 
most tests.15 Reinfections among previously infected patients are also a possibility, 
although it is too early to be determined conclusively. We recommend testing all patients 
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during and soon after the pandemic preoperatively for COVID-19 if the testing capacity is 
present. It is essential to know the specificity and sensitivity of the specific test that is 
being used at an institution when making decisions regarding anesthesia, surgery and the 
use of appropriate PPE. During the pandemic, all patients could be considered to be 
potentially infected with the virus given the possibility of a false negative test. 
Knowledge of the patient’s medications specifically for COVID-19 is also potentially 
impactful information. Hydroxychloroquine, which is now being used for treatment (and in 
some cases prophylaxis after exposure), has potential cardiac side effects including 
cardiomyopathy and prolongation of the QT interval.16 Remdesivir, an RNA synthesis 
inhibitor, is currently being studied as a potential treatment.17 The safety and efficacy of 
this medication in this capacity has yet to be established.  
Currently there is no anesthesia preoperative risk stratification specifically for 
COVID-19 of which we are aware. This is something that may develop as the pandemic 
improves and more surgical cases are performed. The Royal College of Surgeons 
recommends pre-operative chest imaging with a chest x-ray or CT, especially if the patient 
has respiratory symptoms and is unable to be tested for COVID-19 prior to the OR.18 
Intra-operative Care 
Personal Protective Equipment 
Adequate personal protective equipment in the operating room is necessary for 
ensuring the health of individual healthcare providers and maintaining an adequate 
workforce during the pandemic. In addition to the standard operating room personal 
protective equipment of a gown, gloves, mask, and eye protection, there is the question of 
whether an N95 respirator masks should be used for surgeons. Organizations vary in the 
recommendations regarding the use of N95 masks. The American Association of 
Gynecologic Laparoscopists (AAGL) endorses the use of either a standard surgical mask or 
N95 depending on the clinical situation.19 The Royal College of Surgeons recommends 
using an N95 respirator mask during procedures that have the potential to aerosolize the 
virus.18 A task force assembled at Stanford University recommends wearing an N95 mask 
in the setting of a pre-operative positive test for COVID-19.20 They also recommended 
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using a face shield along with the N95 mask to prevent droplets from accumulating, which 
could extend the use of each mask. Recommendations from First Affiliated Hospital in 
China are to wear an N95 mask for all surgical cases.21  The CDC also recommends wearing 
an N95 respirator when operating.22 A randomized controlled trial between N95 and 
standard surgical masks in preventing influenza has been performed and found no 
difference.23  However, this was in the outpatient setting where there is less risk for 
aerosolization of the virus.  
In view of the scarcity of N95 masks and the lack of good evidence to confirm 
transmission of the SARS-CoV-2 during laparoscopy and robotic surgery, Indiana University 
(IU) Health at this time is recommending preoperative testing to determine which patients 
are at highest risk for transmission. If a patient is symptomatic or tests positive for COVID-
19, the surgery should be postponed for at least two weeks.  If postponement is not 
possible, N95 masks are recommended for the surgical staff if aerosol generating 
procedures on the respiratory tract are being performed (i.e. intubation/extubation, 
bronchoscopy, ENT, oral and maxillofacial surgery, and thoracic surgeries). Standard 
surgical masks are recommended for COVID-19 negative patients. This recommendation as 
well as all recommendations related to this pandemic are subject to change as more data 
becomes available. 
Scarcity of personal protective equipment, such as N95 masks, has led to strategies 
to reuse the items to extend their use. If choosing to reuse the N95 mask, the CDC 
recommends using a face shield over the mask to avoid contamination, washing your 
hands after handling the mask, not touching the inside of the mask, and storing it either by 
hanging or placing inside a paper bag.24 The CDC recommends discarding masks following 
aerosol generating procedures, contamination with any body fluids, and close contact with 
infected patients.  The United States Food and Drug Administration (FDA) has approved 
three methods of sterilizing N95 masks during the pandemic using vaporized hydrogen 
peroxide.25 The Battelle Decontamination System can be used a maximum of 20 times to 
reuse a single N95 mask as long as it is not visibly soiled.  The Steris Sterilization System 
can be used up to 10 times.  The Sterrad Sterilization System can be used up to two times. 
Page 8 of 33 
8 
Jo
u
rn
al
 o
f 
En
d
o
u
ro
lo
gy
 
U
ro
lo
gi
c 
su
rg
er
y 
a
n
d
 C
O
V
ID
-1
9
: H
o
w
 t
h
e
 p
a
n
d
em
ic
 is
 c
h
a
n
gi
n
g 
th
e
 w
ay
 w
e
 o
p
er
at
e
 (
D
O
I:
 1
0
.1
0
8
9
/e
n
d
.2
0
2
0
.0
3
4
2
) 
Th
is
 p
a
p
er
 h
as
 b
ee
n
 p
ee
r-
re
vi
ew
ed
 a
n
d
 a
cc
e
p
te
d
 f
o
r 
p
u
b
lic
at
io
n
, b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
go
 c
o
p
ye
d
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. T
h
e 
fi
n
al
 p
u
b
lis
h
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
Ultraviolet C light treatment has also been used.24 In our hospital, the current plan is to re-
process them up to three times. Decontamination of masks at home is not recommended. 
Workflow 
The workflow in the operating room has changed and will evolve as the pandemic 
continues. Drs. Brindle and Gawande offer surgical guidelines to follow during the 
pandemic.26 Among these, they recommend creating a dedicated COVID-19 operating 
space. No unnecessary materials should be brought into the operating room. Entering and 
exiting the room should be kept to a minimum. Similarly, a colorectal surgery group in Italy 
described their experience and recommended precautions including minimizing personnel 
and traffic into and out of the operating room.27 
OR practices surrounding intubation and extubation remain an area of concern as 
these are high-risk instances in patient care when the virus is aerosolized. The American 
Society of Anesthesiologists recommends that the areas in which aerosolization occurs be 
equipped with negative pressure ventilation to prevent transmission to hospital staff.28  
They also recommend having the fewest necessary staff present during intubation and/or 
aerosolizing procedures, especially if the intubation cannot be done in a negative pressure 
room. Most operating rooms are equipped with positive pressure ventilation systems to 
prevent contaminants from entering from outside the operating rooms to help decrease 
the incidence of surgical site infections. Thus, if logistically possible, the patient should be 
intubated in a negative pressure room prior to being transferred to the positive pressure 
operating room.  
Another question is whether there should be a period of time after intubation or 
extubation during which non-essential personnel should remain outside of the room, 
especially if the intubation/extubation is not able to take place in a negative pressure 
room. These time estimates are based on the number of air changes within the room per 
hour.29 The number of air changes per hour depends on the specific operating room, and 
the faster the air is turned over in the room, the quicker the particles are removed. For 
example, if a room has an air turnover rate of roughly 20 times per hour, 99% of particles 
are removed after 14 minutes. Although there is a lack of evidence at this time, it seems 
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reasonable to wait a period of time (length of which depends on the specific OR) after 
intubation before starting the case until more data is available, especially in a positive 
pressure setting.  
Endoscopy 
Thus far most analyses of urine specimens for SARS-CoV-2 have been 
negative.2,30,31 One study in China found SARS-CoV-2 RNA in the urine of four COVID-19 
patients requiring hospitalization out of a total of 58 patients in the cohort.32 In addition to 
urine, the virus RNA has been found in blood specimens. 33 However, blood from COVID-19 
positive patients has been reported to be transfused unknowingly in seven patients, and 
none of the recipients developed symptoms.34 Three of the recipients were tested 2-3 
weeks after the donation and were found to be COVID-19 negative.  Out of caution, care 
should still be taken to minimize trauma during cystoscopy and ureteroscopy. To decrease 
the risk of contamination of equipment, disposable ureteroscopes may be used more 
frequently depending on outcomes as we move forward during the COVID-19 pandemic.   
Another factor to consider for endoscopy is whether to place a stent or 
nephrostomy tube for emergent cases, such as an obstructing stone in the setting of 
infection. According to the Anesthesia Patient Safety Foundation, during procedures that 
require general anesthesia, the highest risk of aerosolization of the virus is during 
intubation and extubation.35 For this reason, a stent placed under sedation without 
intubation or the placement of a nephrostomy tube may be safer than a stent placed in an 
intubated patient. However, this remains an area of debate.  The American Society of 
Anesthesiologists (ASA) states that laryngeal mask airway (LMA) may actually increase the 
risk of aerosolization of SARS-CoV-2 in the setting of high airway pressures and leakage 
around the mask.28 Furthermore, monitored anesthesia care (MAC), although it avoids 
intubation and extubation, could potentially require the anesthesia provider to be closer 
to the patient’s airway and be a potentially greater risk if there is any issue requiring 
manual bagging or unplanned intubation.  The society admits this is only expert opinion 
because there are a lack of studies, but it still remains a valid concern. Adequate 
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neuromuscular blockade during procedures may also help avoid coughing and 
aerosolization of the virus.  
Laparoscopy and Robotics versus Open Surgery 
The potential for aerosolization of SARS-CoV-2 has led organizations such as the 
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) to recommend 
precautions regarding laparoscopic and open surgery.36 They recommend minimizing 
energy use from electrocautery devices to avoid collection of surgical smoke. They 
recommend using insufflation systems with ultra low particulate air (ULPA) filters. 
Additionally, SAGES recommends against using two-way pneumoperitoneum insufflators 
to prevent the pathogens from collecting in the circuit and possibly infecting future 
patients. Although there have been no reported infections from surgical smoke, it remains 
a concern as there is a lack of direct evidence. The current recommendations are based on 
prior research of other viruses that have been detected in surgical smoke, including human 
immunodeficiency virus and papillomavirus.37,38  A recent study in China found that smoke 
concentration is higher during laparoscopic cases compared to open cases,39 which makes 
minimally invasive laparoscopic and robotic surgery particularly vulnerable to possible 
aerosolization of the virus, if present.  In addition to blood, SARS-CoV-2 RNA has been 
found in stool samples.31,40 It is unknown if the virus is present in peritoneal fluid. 
Despite the lack of evidence of transmission of the virus to health care workers 
during laparoscopy, steps are advised to reduce the risk of aerosolization during release of 
pneumoperitoneum and diathermy until more information is available.  Maneuvers that 
can help for minimally invasive surgery are frequent suctioning of smoke in the 
pneumoperitoneum, avoidance of air leaks around ports and during instrument transfers, 
and care in removing ports, especially when pneumoperitoneum is still established. Other 
techniques to consider include using balloon ports or trocars that can be secured to avoid 
pneumoperitoneum leaking at the port sites.  
Ultimately, the choice of procedure should not compromise the patient outcomes 
and laparoscopy and robotics must be used when indicated. The surgeon should carefully 
weigh the pros and cons of each approach.  In addition to reducing exposure to patient 
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and healthcare workers, operating room time, blood loss, length of hospital stay, and risk 
of short and long term complications should be considered. 
Filters 
Although there have been no reported transmissions via surgical smoke, out of 
caution and until more data is obtained, the use of smoke evacuators and surgical 
laparoscopic systems that have appropriate filters for the virus should be considered. The 
size of SARS-CoV-2 virus is 0.06 to 0.14 μm.41 ULPA filters are capable of filtering virus 
particles of this size and are therefore recommended. According to SAGES, the UHI-4 
insufflation system (Olympus, Tokyo, Japan) does not have a ULPA filter, but there are 
other insufflation systems and smoke evacuators that do utilize them: AirSealⓇ(ConMed, 
Utica, NY), SeeClearⓇ (CooperSurgical, Trumbull, CT), egadyne   (Ethicon, Somerville, 
NJ), RapidVac  ( edtronic, inneapolis, N), Pneumoclear  (Stryker, Kalamazoo, I), 
Nebulae  (Northgate Technologies, Elgin, IL), and S-PILOT  (Karl Storz, Tuttlingen, 
Germany). 42 
There may be concerns with two-way insufflation with the above systems. For 
example, with AirSeal®, which is designed to keep the pneumoperitoneum at a constant 
pressure, uses a two-way system in which all of the circulating air may not be filtered 
through the ULPA filter.42 However, the above problem can be remedied by using the 
device in smoke evacuation mode. In this mode, the tubes are set to two standard trocars 
in a closed loop configuration. One connection is for insufflation, and the other for active 
smoke evacuation through a 0.1 micron ULPA filter. In addition to ConMed, most other 
companies have described similar solutions to avoiding the issues with two-way 
insufflation. You should contact the representative of the system at your institution to 
determine the best settings to prevent transmission/aerosolization.  We do not specifically 
endorse any of the above products.  
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Post-operative Care 
Disinfection of Operating Rooms 
Appropriate disinfection of the operating room is vital to preventing transmission 
of the virus to future patients and healthcare workers. Dexter et al describe detailed 
recommendations for decontamination during and after OR procedures during the COVID-
19 pandemic.43 They suggest frequent and thorough handwashing by all members of the 
surgical team.  Exposed equipment, instruments, and trash should be separated from non-
contaminated items to facilitate proper decontamination and decrease risk of exposure. 
The area around the patient and anesthesia work team should be wiped down with a cloth 
containing alcohol and a quaternary ammonium solution. They also recommend the room 
be disinfected with ultraviolet (UV-C) light. Finally, the surgical team should be allowed to 
work in another operating room for the following case to allow time for the first room to 
be deep cleaned.  
The Association of periOperative Registered Nurses (AORN) states that standard 
hospital grade disinfectants that are registered by the Environmental Protection Agency 
are adequate for cleaning operating rooms during the COVID-19 pandemic.44 There should 
be sufficient time between cases to allow for cleaning and to allow for sufficient air 
exchanges in the room to decrease the amount of virus to an acceptable level before the 
next procedure. Consideration should also be given to cleaning the robotic console in 
between cases for robotic surgeons as this is a potential mode of transmission. 
Patient Recovery 
The risk of transmission of SARS-CoV-2 to non-infected patients and healthcare 
workers continues beyond the time of the operation and thus post-operative precautions 
should be taken. The American Society of Anesthesiologists recommends that the surgical 
patient recovers in the operating room after extubation or be transported to an airborne 
infection isolation (AII) room.45 Zheng et al described their experience performing surgery 
in China and Italy during the beginning of the pandemic.46 For containment, they also 
recommend separation of COVID-19 patients from non-infected patients at all levels of 
care including recovery.  Tables 1-3 outline recommendations for pre-, intra-, and post-
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operative care, techniques to decrease the risk of aerosolization, and a summary of 
current recommendations from surgical organizations. 
Conclusions 
A risk-benefit assessment of every urologic patient undergoing surgery should be 
performed during the COVID-19 pandemic based on the urgency of the surgery and the 
risk of the viral illness and transmission. Minimally invasive surgery including laparoscopy 
and robotic surgery should be performed when indicated with attention to minimizing 
potential aerosolization. Routine preoperative testing for COVID-19 and adequate 
protective equipment for the surgical team is essential. Future directions will be guided by 
outcomes and patient infection rates as social distancing guidelines are relaxed and more 
surgical procedures are reintroduced.  Recommendations should be adapted to the local 
environment and will continue to evolve as more data becomes available, the shortage of 
testing and PPE is resolved, and a vaccine and therapeutics for COVID-19 are developed.     
Funding: 
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No conflicts of interest to disclose. 
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Abbreviations Used 
AAGL = American Association of Gynecologic Laparoscopists 
ACS = American College of Surgeons 
AII = airborne infection isolation 
AORN = Association of periOperative Registered Nurses 
ASA = American Society of Anesthesiologists 
CDC = Centers for Disease Control and Prevention 
cm = centimeters 
COVID-19 = coronavirus disease 2019 
CT = computed tomography 
EAU = European Association of Urology 
ENT = ear, nose, and throat 
ERUS = European Association of Urology Robotic Urology Section 
ESAS = Elective Surgery Acuity Scale 
FDA = United States Food and Drug Administration 
IU = Indiana University 
LMA = laryngeal mask airway 
MAC = monitored anesthesia care 
μm = micrometers 
OR = operating room 
PPE = personal protective equipment 
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RCS = Royal College of Surgeons 
RNA = ribonucleic acid 
SAGES = Society of American Gastrointestinal and Endoscopic Surgeons 
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2 
ULPA = ultra low particulate air 
UV-C = ultraviolet C 
WHO = World Health Organization 
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Table 1. Recommendations for pre-, intra-, and post-operative care. (These 
recommendations are subject to continued modification as evidence evolves during the 
COVID-19 pandemic.) 
Pre-operative 
 Postpone elective procedures until the surge of the pandemic has passed.
 Unless emergent, consider SARS-CoV-2 testing and chest imaging for all
patients that need a procedure.
o Ideally perform testing within 48 hours of the procedure.
 Avoid operating on COVID-19 positive patients if possible.
 Use telehealth to perform preoperative counseling and communication when
possible.
 Preoperative counseling should include the risk of contracting the disease
during or after the procedure for COVID-19 negative patients.
Intra-operative 
 If able, choose the anesthesia method that minimizes risk of aerosolization of
the virus.
 If intubation is required for a COVID-19 positive patient, perform the
intubation and extubation in a negative pressure room if available.
o If a negative pressure room for intubation/extubation isn’t available,
have team members except the anesthesia provider and assistant wait
outside the room until 99% of the room’s air has been exchanged (15-
30 minutes for most ORs).
o Anesthesia team to use enhanced PPE including N95 masks or Powered
Air-Purifying Respirator (PAPR).
 Include as few members as possible on the surgical team to minimize virus
transmission.
 For the surgical team, in COVID-19 positive patients, those with unknown
COVID-19 status, and symptomatic patients, N95 mask recommended in
addition to standard PPE.
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o Consider using a face shield or standard surgical mask on top of the
N95 to extend the use of the N95 if resources are scarce.
 Have only equipment essential for the surgery in the room to minimize
contamination.
 Avoid entering and exiting the room as much as possible.
o Have a person outside the room to obtain needed equipment.
 Choose a surgical approach with consideration of aerosolization of the virus,
time in the hospital, blood loss, cancer control, operative time, and surgeon
familiarity with the procedure.
 Regardless of the approach chosen, minimize aerosolization of the virus (see
Table 2).
 Avoid leaving a surgical drain if able.
 Use disposable equipment when possible.
Post-operative 
 For COVID-19 positive patients, recover the patient in the operating room if
possible.
 Create a separate COVID-19 area within the hospital to avoid transmission to
non-infected patients.
 Perform appropriate sterilization and/or disposal of equipment and
instruments.
 Allow adequate time for thorough operating room cleaning.
 Avoid family visits.
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, COVID-19 = coronavirus 
disease 2019, OR = operating room, PPE = personal protective equipment 
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 Table 2. Techniques to decrease the potential risk of aerosolization of SARS-CoV-2 during 
laparoscopic or robotic procedures. (These recommendations are subject to continued 
modification as evidence evolves during the COVID-19 pandemic.)  
Recommendations for minimizing aerosolization of SARS-CoV-2 
 Use an insufflation system with an ultra low particulate air filter.
 Use the lowest insufflation pressure possible to complete the procedure.
 Avoid air leaks during instrument changes, introduction of material into the
peritoneal cavity, and around port sites.
 Use the least duration of cautery and at the lowest possible setting without
compromising surgical outcomes.
 Use a filter for desufflation of pneumoperitoneum and desufflate before ports
are removed.
 Avoid using a two-way circuit for pneumoperitoneum if possible.
 Use suction liberally to avoid smoke accumulation.
 Avoid hand-assisted approaches if possible.
 Use a smoke evacuator if available.
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, COVID-19 = coronavirus 
disease 2019 
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Table 3. Summary of recommendations from surgical organizations.36,42,47,48,49,50
Preope
rative 
Testing 
for 
SARS-
Cov-2 
Minimally Invasive 
Surgery (MIS) vs. Open 
Surgery 
Personal 
Protective 
Equipmen
t 
Intra-
op 
Perso
nnel 
Other 
Recomm
ended 
Equipme
nt 
Extub
ation, 
post-
op 
conval
escenc
e 
Telemedic
ine 
Level of 
Evidence 
American 
College of 
Surgeons (ACS) 
Recom
mend 
COVID-
19 
testing 
when 
possibl
e 
Consider avoiding 
laparoscopy 
Use N95 
respirator
s when 
operating 
if 
available 
Minim
um 
numb
er of 
perso
nnel 
sugge
sted 
Closed 
filtration 
system 
during 
laparosco
py and 
for 
evacuatio
n of the 
pneumop
eritoneu
Minim
um 
numb
er of 
person
nel 
Utilize 
when 
possible 
Expert 
opinion 
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m. Use a
smoke 
evacuato
r. 
Royal College of 
Surgeons (RCS) 
Recom
mend 
testing 
all 
urgent 
patient
s and 
using 
history
, 
testing
, and 
xrays 
to aid 
in 
Consider laparoscopy 
only if clinical benefit 
to the patient exceeds 
the risk of viral 
transmission. 
Filtering 
mask (N95 
or 
greater) 
required 
for 
aerosoliza
tion 
procedure
s 
Standard 
surgical 
mask for 
all other 
Minim
um 
numb
er of 
staff 
in OR. 
Team 
chang
es 
recom
mend
ed for 
prolon
ged 
proce
Smoke 
evacuatio
n devices, 
laparosco
pic filters 
Staff 
imme
diately 
presen
t 
should 
be at a 
minim
um. 
Encourage 
use of 
virtual 
clinics 
Expert 
opinion 
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decisio
n 
non-
aerosol 
producing 
OR 
procedure
s. 
dures 
Society of 
American 
Gastrointestinal 
and Endoscopic 
Surgeons 
(SAGES) 
Test all 
patient
s if 
possibl
e 
Minimal risk of 
transmission during 
laparoscopy. 
N95 and 
face shield 
for 
surgical 
procedure
s and 
endoscop
y 
Essent
ial 
perso
nnel 
prese
nt 
Negative 
pressure 
room for 
intubatio
n, 
electroca
utery on 
lowest 
settings, 
smoke 
evacuator
, 
laparosco
Telemedic
ine should 
be used 
when 
possible 
Expert 
opinion 
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pic filters 
EAU Robotic 
Urology Section 
(ERUS) 
Test all 
patient
s if 
possibl
e 
Perform laparoscopy 
with caution due to the 
increased risk of 
aerosolization. 
Recomme
nd a 
respirator 
mask for 
the 
surgeon. 
Possibly 
wearing a 
sealed 
visor mask 
for the 
console 
surgeon 
Minim
um 
numb
er of 
OR 
staff 
Operate 
at lowest 
pressure 
possible. 
Avoid 
two-way 
pneumop
eritoneu
m 
insufflato
rs to 
prevent 
pathogen 
colonizati
on. 
Expert 
opinion 
American 
Association of 
Gynecologic 
Test 
sympto
matic 
Proceed with caution 
with laparoscopy due 
to theoretical risk 
Standard 
surgical or 
N95 
Minim
al 
perso
Laparosc
opic 
filters, 
Expert 
opinion 
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Laparoscopists 
(AAGL) 
patient
s. If the
testing 
becom
es 
more 
availab
le, 
then 
screen 
all 
patient
s. 
masks 
depending 
on the 
clinical 
situation 
nnel 
prese
nt 
smoke 
evacuator
s 
Indiana 
University (IU) 
Health 
Test all 
patient 
within 
72 
hours 
of 
Perform laparoscopy 
and robotics when 
indicated 
In COVID 
19 
positive or 
COVID 19 
status 
unknown 
Minim
al 
perso
nnel 
prese
nt 
Smoke 
evacuatio
n devices 
and 
laparosco
pic filters 
Negati
ve 
pressu
re 
room 
is 
Utilize 
when 
possible 
Expert 
opinion 
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